Cargando…

Association of dipeptidyl peptidase-4 inhibitor use and the risk of asthma development among type 2 diabetes patients

BACKGROUND: Numerous studies have shown that dipeptidyl peptidase-4 inhibitors (DPP-4i) may regulate immunological pathways implicated in asthma. The association between DPP-4i use and risk of asthma development is limited, however. AIM: We aimed to evaluate if DPP-4i treatment in individuals with t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Peng-Fei, Chung, Chi-Hsiang, Liu, Jhih-Syuan, Lu, Chieh-Hua, Su, Sheng-Chiang, Kuo, Feng-Chih, Ho, Li-Ju, Chen, Kuan-Chan, Su, Yu-Te, Chu, Nain-Feng, Lee, Chien-Hsing, Hsieh, Chang-Hsun, Hung, Yi-Jen, Lin, Fu-Huang, Chien, Wu-Chien, Liang, Yao-Jen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2022
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9716455/ https://www.ncbi.nlm.nih.gov/pubmed/36448591 http://dx.doi.org/10.1177/17534666221135320

Ejemplares similares

Association between the Use of Dipeptidyl Peptidase 4 Inhibitors and the Risk of Dementia among Patients with Type 2 Diabetes in Taiwan
por: Chen, Kuan-Chan, et al.
Publicado: (2020)

Traditional Chinese medicine attenuates hospitalization and mortality risks in diabetic patients with carcinoma in situ in Taiwan
por: Tsai, Li-Jen, et al.
Publicado: (2022)

Serum E-selectin concentration is associated with risk of metabolic syndrome in females
por: Lee, Chien-Hsing, et al.
Publicado: (2019)

Metformin Attenuates Osteoporosis in Diabetic Patients with Carcinoma in Situ: A Nationwide, Retrospective, Matched-Cohort Study in Taiwan
por: Lu, Chieh-Hua, et al.
Publicado: (2020)

Combination of COX-2 inhibitor and metformin attenuates rate of admission in patients with rheumatoid arthritis and diabetes in Taiwan
por: Lu, Chieh-Hua, et al.
Publicado: (2019)

Association between glucokinase regulator gene polymorphisms and serum uric acid levels in Taiwanese adolescents
por: Ho, Li-Ju, et al.
Publicado: (2022)

Pharmacogenetics of dipeptidyl peptidase 4 inhibitors in a Taiwanese population with type 2 diabetes
por: Liao, Wen-Ling, et al.
Publicado: (2017)

High-Molecular-Weight Hyaluronic Acid Inhibits IL-1β-Induced Synovial Inflammation and Macrophage Polarization through the GRP78-NF-κB Signaling Pathway
por: Lee, Chien-Hsing, et al.
Publicado: (2021)

Cilostazol inhibits hyperglucose-induced vascular smooth muscle cell dysfunction by modulating the RAGE/ERK/NF-κB signaling pathways
por: Su, Sheng-Chiang, et al.
Publicado: (2019)

PDIA4, a new endoplasmic reticulum stress protein, modulates insulin resistance and inflammation in skeletal muscle
por: Lee, Chien-Hsing, et al.
Publicado: (2022)

Growth arrest‐specific 6 modulates adiponectin expression and insulin resistance in adipose tissue
por: Su, Sheng‐Chiang, et al.
Publicado: (2020)

Comparison of 7-site skinfold measurement and dual-energy X-ray absorptiometry for estimating body fat percentage and regional adiposity in Taiwanese diabetic patients
por: Kuo, Feng-Chih, et al.
Publicado: (2020)

Dipeptidyl Peptidase-4 deficiency effectively protects the brain and neurological function in rodent after acute Hemorrhagic Stroke
por: Yip, Hon-Kan, et al.
Publicado: (2020)

Soluble Form of Receptor for Advanced Glycation End Products Is Associated with Obesity and Metabolic Syndrome in Adolescents
por: He, Chih-Tsueng, et al.
Publicado: (2014)

DFATs derived from infrapatellar fat pad hold advantage on chondrogenesis and adipogenesis to evade age mediated influence
por: Sun, Yuan-Chao, et al.
Publicado: (2023)

Dipeptidyl peptidase 4 inhibitor use is associated with a lower risk of incident acute kidney injury in patients with diabetes
por: Chao, Chia-Ter, et al.
Publicado: (2017)

The efficacy and safety of combined GLP-1RA and basal insulin therapy among inadequately controlled T2D with premixed insulin therapy
por: Liu, Jhih-Syuan, et al.
Publicado: (2023)

Effects of Dipeptidyl Peptidase-4 Inhibition with MK-0431 on Syngeneic Mouse Islet Transplantation
por: Juang, Jyuhn-Huarng, et al.
Publicado: (2014)

Downregulation of Signaling-active IGF-1 by Dipeptidyl Peptidase IV (DPP-IV)
por: Lin, Ching-Ting, et al.
Publicado: (2010)

Genetic variants of dipeptidyl peptidase IV are linked to the clinicopathologic development of prostate cancer
por: Wen, Yu‐Ching, et al.
Publicado: (2023)

Association between Add-On Dipeptidyl Peptidase-4 Inhibitor Therapy and Diabetic Retinopathy Progression
por: Kang, Eugene Yu-Chuan, et al.
Publicado: (2021)

Cilostazol attenuates the severity of peripheral arterial occlusive disease in patients with type 2 diabetes: the role of plasma soluble receptor for advanced glycation end-products
por: Liu, Jhih-Syuan, et al.
Publicado: (2015)

Abelmoschus esculentus subfractions improved nephropathy with regulating dipeptidyl peptidase-4 and type 1 glucagon-like peptide receptor in type 2 diabetic rats
por: Peng, Chiung-Huei, et al.
Publicado: (2018)

Role of dipeptidyl peptidase-4 inhibitors in patients with diabetes infected with coronavirus-19
por: Chen, Chun-Fan, et al.
Publicado: (2020)

The Dipeptidyl Peptidase-4 Inhibitor Linagliptin Ameliorates Endothelial Inflammation and Microvascular Thrombosis in a Sepsis Mouse Model
por: Wang, Shen-Chih, et al.
Publicado: (2022)

A novel potential biomarker for metabolic syndrome in Chinese adults: Circulating protein disulfide isomerase family A, member 4
por: Chien, Chu-Yen, et al.
Publicado: (2017)

LncRNA HOTAIR impairs the prognosis of papillary thyroid cancer via regulating cellular malignancy and epigenetically suppressing DLX1
por: Kuo, Feng-Chih, et al.
Publicado: (2022)

Plasma Protein Growth Arrest–Specific 6 Levels Are Associated With Altered Glucose Tolerance, Inflammation, and Endothelial Dysfunction
por: Hung, Yi-Jen, et al.
Publicado: (2010)

New insights into the role of dipeptidyl peptidase 8 and dipeptidyl peptidase 9 and their inhibitors
por: Cui, Chenkai, et al.
Publicado: (2022)

Dipeptidyl peptidase 4 promotes peritoneal fibrosis and its inhibitions prevent failure of peritoneal dialysis
por: Li, Yi-Chen, et al.
Publicado: (2021)

Combination COX-2 inhibitor and metformin attenuate rate of joint replacement in osteoarthritis with diabetes: A nationwide, retrospective, matched-cohort study in Taiwan
por: Lu, Chieh-Hua, et al.
Publicado: (2018)

High glucose induces human endothelial dysfunction through an Axl-dependent mechanism
por: Lee, Chien-Hsing, et al.
Publicado: (2014)

All-cause mortality of insulin plus dipeptidyl peptidase-4 inhibitors in persons with type 2 diabetes
por: Yen, Fu-Shun, et al.
Publicado: (2019)

Gender-specific impacts of thigh skinfold thickness and grip strength for predicting osteoporosis in type 2 diabetes
por: Lu, Chieh-Hua, et al.
Publicado: (2023)

Abelmoschus esculentus subfractions ameliorate hepatic lipogenesis and lipid uptake via regulating dipeptidyl peptidase-4—With improving insulin resistance
por: Peng, Chiung-Huei, et al.
Publicado: (2022)

Soluble Dipeptidyl Peptidase-4 Induces Fibroblast Activation Through Proteinase-Activated Receptor-2
por: Lee, Shih-Yi, et al.
Publicado: (2020)

Serum and Adipose Dipeptidyl Peptidase 4 in Cardiovascular Surgery Patients: Influence of Dipeptidyl Peptidase 4 Inhibitors
por: Shibasaki, Ikuko, et al.
Publicado: (2022)

Elevated Human Dipeptidyl Peptidase 4 Expression Reduces the Susceptibility of hDPP4 Transgenic Mice to Middle East Respiratory Syndrome Coronavirus Infection and Disease
por: Algaissi, Abdullah, et al.
Publicado: (2019)

Improvement in Mortality and End-Stage Renal Disease in Patients With Type 2 Diabetes After Acute Kidney Injury Who Are Prescribed Dipeptidyl Peptidase-4 Inhibitors
por: Chen, Cheng-Yi, et al.
Publicado: (2018)

Reference ranges for ultrasonographic renal dimensions as functions of age and body indices: A retrospective observational study in Taiwan
por: Su, Hsuan-An, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_gce2vr894n0d08mbnpbb37hp30